VOYA Investment Management’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-812,247
| Closed | -$15.3M | – | 2712 |
|
|
2019
Q3 | $15.3M | Buy |
812,247
+46,330
| +6% | +$530K | 0.03% | 471 |
|
|
2019
Q2 | $9.02M | Buy |
765,917
+742,244
| +3,135% | +$8.99M | 0.02% | 638 |
|
|
2019
Q1 | $323K | Sell |
23,673
-1,234
| -5% | -$16K | ﹤0.01% | 2019 |
|
|
2018
Q4 | $255K | Hold |
24,907
| – | – | ﹤0.01% | 2113 |
|
|
2018
Q3 | $415K | Sell |
24,907
-1,049
| -4% | -$19K | ﹤0.01% | 1959 |
|
|
2018
Q2 | $410K | Sell |
25,956
-2,433
| -9% | -$37K | ﹤0.01% | 1949 |
|
|
2018
Q1 | $361K | Hold |
28,389
| – | – | ﹤0.01% | 2003 |
|
|
2017
Q4 | $325K | Hold |
28,389
| – | – | ﹤0.01% | 2090 |
|
|
2017
Q3 | $348K | Buy |
28,389
+6,085
| +27% | +$63.4K | ﹤0.01% | 2085 |
|
|
2017
Q2 | $255K | Buy |
22,304
+1,734
| +8% | +$32.1K | ﹤0.01% | 2266 |
|
|
2017
Q1 | $428K | Hold |
20,570
| – | – | ﹤0.01% | 1812 |
|
|
2016
Q4 | $428K | Hold |
20,570
| – | – | ﹤0.01% | 1845 |
|
|
2016
Q3 | $674K | Hold |
20,570
| – | – | ﹤0.01% | 1562 |
|
|
2016
Q2 | $514K | Buy |
20,570
+10,071
| +96% | +$272K | ﹤0.01% | 1699 |
|
|
2016
Q1 | $257K | Hold |
10,499
| – | – | ﹤0.01% | 2092 |
|
|
2015
Q4 | $347K | Hold |
10,499
| – | – | ﹤0.01% | 1962 |
|
|
2015
Q3 | $344K | Hold |
10,499
| – | – | ﹤0.01% | 1961 |
|
|
2015
Q2 | $556K | Buy |
+10,499
| New | +$382K | ﹤0.01% | 1840 |
|
VOYA Investment Management's ALDR Position: Q4 2019 in Review
VOYA Investment Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 812,247 shares — an estimated $15.3M sold.
VOYA Investment Management first reported a position in ALDR in Q2 2015 and held it in 18 quarters. The position peaked at $15.3M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- VOYA Investment Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- VOYA Investment Management sold 812,247 Alder Biopharmaceuticals shares in Q4 2019, an estimated $15.3M.
- VOYA Investment Management first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 18 quarters.
- VOYA Investment Management's Alder Biopharmaceuticals position peaked at $15.3M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on VOYA Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.